Lower incidence of bronchiolitis obliterans in pediatric liver-lung transplant recipients with cystic fibrosis

Transplantation

Volumn 83, Issue 11, 2007, Pages 1435-1439

  Faro, Albert ^a   Shepherd, Ross ^a   Huddleston, Charles B ^b   Lowell, Jeffrey ^b   Gandhi, Sanjiv ^b   Nadler, Michelle ^a   Sweet, Stuart C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Bronchiolitis obliterans; Cystic fibrosis; Liver transplantation; Lung transplantation; Pediatrics

Indexed keywords

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; CASE CONTROL STUDY; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; INCIDENCE; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; MEDICAL RECORD REVIEW; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PATIENT REFERRAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; SURGICAL PATIENT; SURVIVAL TIME;

ADOLESCENT; BRONCHIOLITIS OBLITERANS; CASE-CONTROL STUDIES; CYSTIC FIBROSIS; FEMALE; GRAFT REJECTION; HUMANS; INCIDENCE; LIVER DISEASES; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MULTIPLE ORGAN FAILURE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34250617423     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000266067.44499.07     Document Type: Article

References (25)

1. Barshes NR, Dibardino DJ, McKenzie ED, et al. Combined lung and liver transplantation: The United States Experience. Transplantation 2005; 80: 1161.
2. Creput C, Durrbach A, Samuel D, et al. Incidence of renal and liver rejection and patient survival rate following combined liver and kidney transplantation. Am J Transplant 2003; 3: 348.
3. Gonwa TA, Nery JR, Husberg BS, Klintmalm GB. Simultaneous liver and renal transplantation in man. Transplantation 1988; 46: 690.
4. Margreiter R, Kramar R, Huber C, et al. Combined liver and kidney transplantation. Lancet 1984; 1: 1077.
5. Margreiter R, Kornberger R, Koller J, Steiner F, Spielberger M, Aigner F, Scmid T, Aulitzky W, Vogel W. Preliminary results with combined hepatorenal transplantation. Transplant Proc 1987; 19: 3552.
6. Boucek MM, Edwards LB, Keck BM, Trulock EP, Taylor DO, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: Eighth official pediatric report - 2005. J Heart Lung Transplant 2005; 24: 968.
7. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996; 15: 1.
8. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant 1993; 12: 713.
9. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297.
10. Corcoran TE, Smaldone GC, Dauber JH, et al. Preservation of posttransplant lung function with aerosol cyclosporin. Eur Respir J 2004; 23: 378.
11. Date H, Lynch JP, Sundaresan S, Patterson GA, Trulock EP. The impact of cytolytic therapy on bronchiolitis obliterans syndrome. J Heart Lung Transplant 1998; 17: 869.
12. Dusmet M, Maurer J, Winton T, Kesten S. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant 1996; 15: 948.
13. Iacono AT, Corcoran TE, Griffith BP, et al. Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans. Eur Respir J 2004; 23: 384.
14. Roman A, Bravo C, Monforte V, Reyes L, Canela M, Morell F. Preliminary results of rescue therapy with tacrolimus and mycophenolate mofetil in lung transplanted patients with bronchiolitis obliterans. Transplant Proc 2002; 34: 146.
15. Verleden GM, Dupont LJ. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2004; 77: 1465.
16. Couetil JP, Houssin DP, Soubrane O, et al. Combined lung and liver transplantation in patients with cystic fibrosis. A 4 1/2-year experience. J Thorac Cardiovasc Surg 1995; 110: 1415, discussion 1422.
17. Rasmussen A, Davies HF, Jamieson NV, Evans DB, Calne RY. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 1995; 59: 919.
18. Calne RY, Sells RA, Pena JR, et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472.
19. Opelz G, Margreiter R, Dohler B. Prolongation of long-term kidney graft survival by a simultaneous liver transplant: The liver does it, and the heart does it too. Transplantation 2002; 74: 1390-4 discussion 1370.
20. Davis HS, Pollard SG, Calne RY. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 1989; 47: 524.
21. Zavazava N, Kronke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat Med 1996; 2: 1005.
22. Graeb C, Scherer MN, Knechtle SJ, Geissler EK. Immunologic suppression mediated by genetically modified hepatocytes expressing secreted allo-MHC class I molecules. Hum Immunol 1998; 59: 415.
23. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992; 339: 1579.
24. Kataoka M, Margenthaler JA, Ku G, Eilers M, Flye MW. "Infectious tolerance" develops after the spontaneous acceptance of Lewis-to-Dark Agouti rat liver transplants. Surgery 2003; 134: 227.
25. Asakura H, Ku G, Kataoka M, Flye MW. Regulatory cells develop after the spontaneous acceptance of rat liver allografts. Surgery 2004; 136: 532.